Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.380 Biomarker phenotype CTD_human Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury. 28762043 2018
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.380 Biomarker phenotype BEFREE Here, we uncover a critical role for SHP in circadian regulation of cytochromes P450 (CYPs) and drug-induced hepatotoxicity. 30555544 2018
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.380 GeneticVariation phenotype BEFREE Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population. 28389387 2017
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.380 GeneticVariation phenotype BEFREE Association of the CYP2B6 gene with anti-tuberculosis drug-induced hepatotoxicity in a Brazilian Amazon population. 25271170 2015
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.380 Biomarker phenotype BEFREE Multivariate cox regression model indicated that CYP2B6*6/*6 genotype and anti-HCV IgG antibody positive as significant predictors of DILI. 22808112 2012
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.380 AlteredExpression phenotype BEFREE The use of hepatoma cell lines, such as HepG2 cell line, for the evaluation of drug-induced hepatotoxicity is hampered by their low cytochrome P450 expression which makes impossible the study of the toxicity produced by bioactivable compounds. 22138474 2012
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.380 Biomarker phenotype BEFREE CYP2B6 genotyping and/or regular monitoring of EFV and lever enzymes level during early therapy is advised for early diagnosis and management of DILI. 21862974 2012
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.380 GeneticVariation phenotype BEFREE Genetic polymorphisms of cytochrome P450 and glutathione S-transferase associated with antituberculosis drug-induced hepatotoxicity in Chinese tuberculosis patients. 20819434 2010
Entrez Id: 1555
Gene Symbol: CYP2B6
CYP2B6
0.380 GeneticVariation phenotype BEFREE Risk factors for DILI include age, sex and genetic polymorphisms of drug-metabolising enzymes such as cytochrome P450. 17967156 2007